# Hepatolenticular degeneration-induced hepatic dysfunction with extremely atypical clinical manifestations: a Case Report

**Authors:** Zhuang Tao, Jiafeng Zhou, Zhenzhen Jiang, Ya Hu, Shupei Jia, Meixia Wang

PMC · DOI: 10.3389/fmed.2025.1599283 · Frontiers in Medicine · 2025-05-14

## TL;DR

This case report describes a rare liver-brain disorder with unusual symptoms, highlighting new genetic mutations and atypical diagnostic challenges.

## Contribution

The paper reports a novel mutation in HLD with atypical clinical features and normal biochemical markers.

## Key findings

- A 43-year-old male presented with HLD but lacked typical clinical and biochemical signs.
- Genetic testing revealed new mutation sites not previously associated with typical HLD manifestations.
- The case emphasizes the importance of genetic testing in atypical HLD presentations.

## Abstract

Hepatolenticular Degeneration (HLD) is a rare condition caused by a genetic copper metabolism disorder and a basal ganglia-dominated degenerative brain disease. Its characteristic clinical features include progressive extrapyramidal symptoms, psychiatric manifestations, cirrhosis, renal impairment, and the Kayser-Fleischer ring. Furthermore, its key diagnostic bases include the ceruloplasmin level, copper oxidase activity, trace copper in the human body, brain Magnetic Resonance Imaging (MRI), and genetic testing. Here, we present an HLD case with atypical clinical manifestations. A 43-year-old male HLD patient presented to our hospital with normal copper oxidase activity and serum copper levels, as well as results of ceruloplasmin testing, slit-lamp examination, and histopathological examination of the liver, which showed no typical manifestations. On the other hand, the genetic testing results showed new mutation sites. To improve our clinical understanding of HLD and reduce the probability of misdiagnosis and missed diagnosis, we discussed and clarified the clinical manifestations, pathogenesis, and diagnosis and treatment of the disease, all based on existing literature.

## Linked entities

- **Diseases:** Hepatolenticular Degeneration (MONDO:0010200), cirrhosis (MONDO:0005155)

## Full-text entities

- **Genes:** CP (ceruloplasmin) [NCBI Gene 1356] {aka AB073614, CP-2}
- **Diseases:** copper metabolism disorder (MESH:C535468), hepatic dysfunction (MESH:D008107), degenerative brain disease (MESH:D019636), extrapyramidal symptoms (MESH:D001480), cirrhosis (MESH:D005355), psychiatric (MESH:D001523), HLD (MESH:D006527), renal impairment (MESH:D007674)
- **Chemicals:** copper (MESH:D003300)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12116486/full.md

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12116486/full.md

## References

18 references — full list in the complete paper: https://tomesphere.com/paper/PMC12116486/full.md

---
Source: https://tomesphere.com/paper/PMC12116486